Clinical Trials on Moderate to Severe Glabellar Line in Hong Kong
Total 11 results
-
The University of Hong KongSuspendedMild to Moderate Depressive SymptomsChina
-
The University of Hong KongRecruiting
-
The Hong Kong Polytechnic UniversityUnknownOlder Adults With Mild to Moderate Level of DementiaHong Kong
-
Food and Health Bureau, Hong KongHospital Authority, Hong KongRecruitingChronic Obstructive Pulmonary Disease SevereChina
-
Shanghai JunTop Biosciences Co., LTDSponsor GmbHTerminated
-
Egalet LtdCompletedModerate-to-severe Chronic Low Back PainUnited States
-
Alkahest, Inc.CompletedAlzheimer Disease | Mild to Moderate Alzheimer DiseaseUnited States
-
AmgenActive, not recruitingAtopic Dermatitis | Moderate-to-severe Atopic DermatitisUnited States, Canada
-
Regeneron PharmaceuticalsSanofiCompletedHypersensitivity, Immediate | Dermatitis, Atopic | Moderate-to-Severe Atopic Dermatitis | Dermatitis, Dermatitis Atopic | Eczema, Skin Diseases, Skin | Diseases Genetic, Genetic | Diseases Inborn, Skin | Disease, Eczematous Skin | Hypersensitivity, Immune System DiseasesUnited States, Canada
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19United States, United Kingdom, Belgium, Spain, France, Germany, Philippines, Brazil, Colombia, South Africa
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the ProtocolUnited States, Mexico, South Africa, Brazil, Chile, Colombia, Peru, Argentina